A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Monte Rosa Therapeutics, Inc
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
Cyteir Therapeutics, Inc.
Fate Therapeutics
Opna Bio LLC
Novartis
Institut Bergonié
Incyte Corporation
MultiVir, Inc.
Celgene
AbbVie
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Amgen
Novartis
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Utah
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center